Lori D. Parisi

Bio:

Lori Parisi is Vice President, Global Medical Affairs, Hematology at Johsnon & Johnson. She leads a high performing, diverse team of Global Medical Affairs Leaders across multiple disease areas, including B-cell Malignancies, Multiple Myeloma and Myeloid Malignancies, encompassing 5 globally marketed compounds and several in early development. In this role she shapes portfolio and asset medical strategies, including worldwide evidence generation activities, to grow J&J’s industry-leading hematology portfolio and champion worldwide medical adoption of our transformational therapies. 

Lori began her career with Johnson & Johnson an Oncology sales representative. Since then, she has more than 20 years of medical affairs experience within J&J, including US and Global roles across Oncology and Infectious Diseases. Most recently, she was the Senior Global Medical Affairs Leader for IMBRUVICA, a transformational therapy for B-cell malignancies. Prior to joining the Oncology Global Medical Affairs team, Lori worked for 10 years within the US Medical Affairs organization leading publication strategy, medical education and philanthropic giving in HIV and Hepatitis C.

Lori graduated from Northwestern University with a Bachelor of Science Degree in Biomedical Engineering and earned a Master’s Degree in Public Health (MPH) from Columbia University.